Aurobindo Pharma subsidiary’s plant in Andhra Pradesh issued five observations by U.S. FDA
The Hindu
Aurobindo Pharma's subsidiary receives five observations from the U.S. FDA
More Related News

Insurance penetration and density are often misunderstood and do not reveal how many families are insured or whether they would be financially secure if the main earning member were to die. The real issue is not reach but adequacy, as households may have life insurance but not enough cover to replace lost income, leaving them financially vulnerable.












